More
    Guided Solutions - Connecting Talent With Innovation/div>

    Perimeter completes enrolment for AI-assisted breast imaging trial

    Perimeter Medical Imaging AI has completed enrolment for the pivotal trial of its AI-assisted imaging technology, the Perimeter B-Series OCT system, for performing breast-conserving...

    PARKEO2 clinical trial reaches key enrolment milestone ahead of schedule

    RebrAIn, a leader in precise targeting solutions for deep brain stimulation (DBS) and lesion techniques, announced the successful early completion of recruitment for the...

    Synchron reports positive results from Command study of its BCI system

    Brain-computer interface (BCI) developer Synchron said there were no serious adverse events in its 12-month Command study, which also showed reliable performance of the...

    Toro Neurovascular’s catheter trial begins with first patient in Japan

    Toro Neurovascular announced the successful treatment of the first patient in a first-in-man clinical trial of its Toro 88 SuperBore Aspiration Catheter for acute...

    Hyperfine’s Swoop MRI system trumps standard MRIs in interim study

    Hyperfine has presented positive interim data from the ACTION PMR study, demonstrating that its magnetic resonance brain imaging (MRI) Swoop system offers faster time-to-scan...

    DermaSensor’s skin cancer detection device helps clinicians in published study

    US-based DermaSensor has announced a newly published study showing that its AI-powered device can improve a primary care physician’s ability to assess moles of...

    Sparta Biomedical implants Ormi device in first-in-human trial

    Medical device company Sparta Biomedical has announced the successful implantation of its Ormi device in a first-in-human clinical trial. Designed to treat knee osteoarthritis, the...

    Alio starts trial to expand label for remote monitoring device

    Alio plans to increase the use case for its wearable remote monitoring SmartPatch technology to monitor health metrics in dialysis patients without vascular accesss...

    CVRx touts positive two-year data for heart failure neuromodulation device

    Building on long-term data announced earlier this year, CVRx has reported durable improvements in heart failure patients with its Barostim device over 24 months. The...

    Latest articles